Chemed Corp. Company Profile (NYSE:CHE)

About Chemed Corp.

Chemed Corporation operates and divests subsidiaries engaged in diverse business activities. The Company operates its business in two segments: the VITAS segment (VITAS) and the Roto-Rooter segment (Roto-Rooter). The Company's VITAS segment provides hospice and palliative care services to its patients through a network of physicians, registered nurses, home health aides, social workers, clergy and volunteers. VITAS segment provides hospice care to Medicare beneficiaries receiving their non-hospice healthcare services from health maintenance organizations (HMOs) under Medicare risk contracts. The Company and its subsidiaries also own training manuals, cost information, patient information and software source codes. A portion of its VITAS business is operated in the state of Florida. The Company's Roto-Rooter segment provides plumbing, drain cleaning, water restoration and other related services to both residential and commercial customers.

Industry, Sector and Symbol:

Sector: Medical
Industry: Home Health Care
Sub-Industry: Health Care Services
Exchange: NYSE
Symbol: CHE
CUSIP: 16359R10

Key Metrics:

Previous Close: $140.39
50 Day Moving Average: $136.95
200 Day Moving Average: $135.66
52-Week Range: $124.77 - $160.12
Trailing P/E Ratio: 22.27
Foreward P/E Ratio: 17.84
P/E Growth: 1.96
Market Cap: $2.27B
Outstanding Shares: 16,190,000
Beta: 1.14

Profitability:

Net Margins: 6.93%
Return on Equity: 24.12%
Return on Assets: 13.48%

Debt:

Debt-to-Equity Ratio: 0.30%
Current Ratio: 0.88%
Quick Ratio: 0.84%

Additional Links:

Companies Related to Chemed Corp.:

Consensus Ratings for Chemed Corp. (NYSE:CHE) (?)

Ratings Breakdown:	3 Hold Ratings, 1 Buy Rating
Consensus Rating:	Hold (Score: 2.25)
Consensus Price Target:	$159.67 (13.73% upside)

Analysts' Ratings History for Chemed Corp. (NYSE:CHE)

Show:

Date	Firm	Action	Rating	Price Target
9/27/2016	Oppenheimer Holdings Inc.	Reiterated Rating	Outperform	$155.00
9/4/2016	JMP Securities	Reiterated Rating	Hold
7/27/2016	RBC Capital Markets	Reiterated Rating	Sector Perform	$136.00 -> $162.00
7/27/2016	Royal Bank Of Canada	Boost Price Target	Sector Perform	$136.00 -> $162.00
9/15/2015	Deutsche Bank AG	Reiterated Rating	Buy

(Data available from 9/28/2014 forward)

Earnings History for Chemed Corp. (NYSE:CHE)

Date	Quarter	Consensus Estimate	Actual EPS	Revenue Estimate	Actual Revenue	Release Link	Conference Call
10/20/2016
7/25/2016	Q216	$1.72	$1.80	$393.50 million	$290.00 million	View	Listen
4/28/2016	Q116	$1.58	$1.62	$391.68 million	$390.40 million	View	Listen
2/17/2016	Q415	$1.81	$1.97	$390.22 million	$398.60 million	View	Listen
10/22/2015	Q315	$1.61	$1.78	$375.95 million	$386.23 million	View	Listen
7/23/2015	Q215	$1.59	$1.71	$375.01 million	$382.00 million	View	Listen
4/28/2015	Q115	$1.44	$1.54	$370.76 million	$377.00 million	View	Listen
2/17/2015	Q414	$1.69	$1.80	$372.54 million	$379.00 million	View	Listen
10/30/2014	Q314	$1.51	$1.48	$360.00 million	$358.40 million	View	Listen
7/23/2014	Q214	$1.47	$1.50	$363.73 million	$360.18 million	View	Listen
4/29/2014	Q114	$1.32	$1.32	$256.77 million	$358.30 million	View	Listen
10/29/2013	Q313	$1.34	$1.36	$355.40 million	$340.90 million	View	Listen
7/18/2013	Q2 2013	$1.33	$1.44	$368.06 million	$357.00 million	View	Listen
4/18/2013	Q1 2013	$1.29	$1.38	$365.08 million	$367.00 million	View	Listen
2/18/2013	Q4 2012	$1.15	$1.57	$355.31 million	$369.00 million	View	Listen
10/29/2012	Q312	$1.35	$1.28	$360.50 million	$354.00 million	View	N/A
7/25/2012		$1.26	$1.26			View	N/A
4/19/2012		$1.25	$1.21			View	N/A
2/14/2012		$1.48	$1.45			View	N/A
10/25/2011		$1.15	$1.20			View	N/A
4/26/2011		$0.98	$1.07			View	N/A
2/15/2011		$1.05	$0.98			View	N/A

(Data available from 1/1/2011 forward)

Earnings Estimates for Chemed Corp. (NYSE:CHE)

Current Year EPS Consensus Estimate: $7.06 EPS
Next Year EPS Consensus Estimate: $7.87 EPS

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate
Q1 2016	1	$1.58	$1.58	$1.58
Q2 2016	1	$1.74	$1.74	$1.74
Q3 2016	1	$1.80	$1.80	$1.80
Q4 2016	1	$2.08	$2.08	$2.08
Q1 2017	2	$1.76	$1.83	$1.80
Q2 2017	1	$1.90	$1.90	$1.90
Q3 2017	1	$1.95	$1.95	$1.95
Q4 2017	1	$2.24	$2.24	$2.24

(Data provided by Zacks Investment Research)

Current Dividend Information for Chemed Corp. (NYSE:CHE)

Annual Dividend:	$1.04
Dividend Yield:	0.74%
Dividend Growth:	10.60% (3 Year Average)
Payout Ratio:	16.51% (Based on Trailing 12 Months of Earnings) 14.73% (Based on Current Year Consensus EPS Estimate) 13.21% (Based on Next Year Consensus EPS Estimate)
Track Record:	7 Years of Consecutive Dividend Growth

Dividend History for Chemed Corp. (NYSE:CHE)

Announced	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
8/5/2016	quarterly	$0.26	0.72%	8/11/2016	8/15/2016	9/2/2016
5/16/2016	quarterly	$0.24	0.76%	5/24/2016	5/26/2016	6/15/2016
2/19/2016	quarterly	$0.24	0.75%	2/25/2016	2/29/2016	3/21/2016
11/6/2015	quarterly	$0.24	0.63%	11/12/2015	11/16/2015	12/7/2015
8/7/2015	quarterly	$0.24	0.63%	8/13/2015	8/17/2015	9/4/2015
5/18/2015	quarterly	$0.22	0.71%	5/26/2015	5/28/2015	6/17/2015
2/20/2015	quarterly	$0.22	0.77%	2/26/2015	3/2/2015	3/23/2015
11/7/2014	quarterly	$0.22	0.81%	11/13/2014	11/17/2014	12/8/2014
8/11/2014	quarterly	$0.22	0.88%	8/14/2014	8/18/2014	9/13/2014
8/8/2014	quarterly	$0.22		8/14/2014	8/18/2014	9/3/2014
5/19/2014	quarterly	$0.20	0.91%	5/27/2014	5/29/2014	6/18/2014
2/21/2014	quarterly	$0.20	0.94%	2/27/2014	3/3/2014	3/24/2014
11/8/2013	quarterly	$0.20	1.13%	11/14/2013	11/18/2013	12/9/2013
8/2/2013	quarterly	$0.20	1.1%	8/8/2013	8/12/2013	9/3/2013
5/20/2013	quarterly	$0.18	1.05%	5/28/2013	5/30/2013	6/19/2013
2/20/2013	quarterly	$0.18	0.92%	2/28/2013	3/4/2013	3/22/2013

(Data available from 1/1/2013 forward)

Insider Trading History for Chemed Corp. (NYSE:CHE)

Insider Ownership Percentage: 5.32%
Institutional Ownership Percentage: 98.62%

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction
9/22/2016	Spencer S Lee	Insider	Sell	2,000	$141.67	$283,340.00
8/8/2016	Donald E Saunders	Director	Sell	500	$144.32	$72,160.00
8/5/2016	Arthur V Tucker Jr	VP	Sell	4,500	$144.28	$649,260.00
8/4/2016	Arthur V Tucker Jr	VP	Sell	3,089	$143.88	$444,445.32
8/3/2016	Kevin J Mcnamara	Insider	Sell	18,000	$144.87	$2,607,660.00
5/16/2016	Donald E Saunders	Director	Buy	77	$126.53	$9,742.81
3/21/2016	Spencer S Lee	EVP	Sell	24,382	$132.29	$3,225,494.78
1/27/2016	Patrick P Grace	Director	Sell	50	$138.98	$6,949.00
12/11/2015	David Patrick Williams	CFO	Sell	5,000	$151.72	$758,600.00
11/24/2015	Spencer S Lee	EVP	Sell	5,000	$154.10	$770,500.00
11/6/2015	Kevin J Mcnamara	CEO	Sell	6,000	$157.02	$942,120.00
10/27/2015	Spencer S. Lee	EVP	Sell	4,000	$153.64	$614,560.00
10/26/2015	Kevin J. Mcnamara	CEO	Sell	8,000	$149.04	$1,192,320.00
8/24/2015	David Patrick Williams	CFO	Sell	10,000	$138.09	$1,380,900.00
5/15/2015	Arthur V Tucker Jr	VP	Sell	9,000	$121.00	$1,089,000.00
5/7/2015	Kevin J Mcnamara	CEO	Sell	8,000	$120.82	$966,560.00
3/6/2015	Spencer S Lee	EVP	Sell	9,931	$115.16	$1,143,653.96
3/2/2015	Timothy S Otoole	EVP	Sell	10,000	$117.82	$1,178,200.00
2/27/2015	Arthur V Tucker Jr	VP	Sell	7,000	$116.80	$817,600.00
2/24/2015	Arthur V Tucker Jr	VP	Sell	2,685	$114.35	$307,029.75
2/23/2015	Spencer S Lee	EVP	Sell	10,000	$113.18	$1,131,800.00
2/20/2015	Kevin J Mcnamara	CEO	Sell	13,000	$112.71	$1,465,230.00
11/14/2014	Timothy S Otoole	EVP	Sell	5,000	$106.81	$534,050.00
11/13/2014	Spencer S Lee	EVP	Sell	10,000	$108.38	$1,083,800.00
11/4/2014	Kevin J Mcnamara	CEO	Sell	4,000	$104.13	$416,520.00
9/10/2014	Spencer S Lee	EVP	Sell	2,000	$105.80	$211,600.00
9/8/2014	David Patrick Williams	CFO	Sell	5,000	$105.90	$529,500.00
8/7/2014	Kevin J Mcnamara	CEO	Sell	5,000	$100.05	$500,250.00
7/25/2014	Arthur V Tucker Jr	VP	Sell	9,000	$101.26	$911,340.00
7/25/2014	Kevin J Mcnamara	CEO	Sell	10,000	$101.00	$1,010,000.00
5/15/2014	Timothy Otoole	EVP	Sell	9,000	$87.62	$788,580.00
5/5/2014	Kevin Mcnamara	CEO	Sell	5,000	$85.05	$425,250.00
4/2/2014	Spencer Lee	EVP	Sell	2,000	$90.15	$180,300.00
3/19/2014	Thomas Hutton	VP	Sell	2,201	$88.36	$194,480.36
3/11/2014	Timothy Otoole	EVP	Sell	6,000	$86.60	$519,600.00
3/3/2014	Kevin Mcnamara	CEO	Sell	4,000	$84.47	$337,880.00
2/28/2014	Arthur Tucker, Jr.	VP	Sell	9,000	$85.01	$765,090.00
2/25/2014	Arthur Tucker, Jr.	VP	Sell	8,461	$83.80	$709,031.80
2/20/2014	Spencer Lee	EVP	Sell	2,000	$82.51	$165,020.00
2/19/2014	Kevin Mcnamara	CEO	Sell	4,000	$82.18	$328,720.00

(Data available from 1/1/2013 forward)

Latest Headlines for Chemed Corp. (NYSE:CHE)

Date	Headline
	executive vice president of Chemed Corp (NYSE:CHE), Lee Spencer S, sells 2,000 shares worth $283,340 (NYSE:CHE) empowerednews.net - September 24 at 8:26 AM
	Chemed Corp. – Value Analysis (NYSE:CHE) : September 12, 2016 (NYSE:CHE) www.capitalcube.com - September 12 at 4:02 PM
	Chemed Corp. breached its 50 day moving average in a Bullish Manner : CHE-US : September 9, 2016 (NYSE:CHE) www.capitalcube.com - September 9 at 9:02 AM
	CHE Makes Bullish Cross Above Critical Moving Average (NYSE:CHE) www.nasdaq.com - September 8 at 5:43 AM
	Chemed Corporation to Present at the Morgan Stanley Global Healthcare Conference (NYSE:CHE) finance.yahoo.com - September 7 at 8:39 AM
	Chemed is Now Oversold (CHE) (NYSE:CHE) www.nasdaq.com - August 19 at 11:55 AM
	New market study, "Chemed Corporation (CHE) - Financial and Strategic SWOT Analysis Review", has been published (NYSE:CHE) www.live-pr.com - August 16 at 9:29 PM
	Chemed Corp. breached its 50 day moving average in a Bearish Manner : CHE-US : August 16, 2016 (NYSE:CHE) www.capitalcube.com - August 16 at 9:34 AM
	Chemed (CHE) Shares Cross Below 200 DMA (NYSE:CHE) www.nasdaq.com - August 12 at 9:26 PM
	Director of Chemed Corp (NYSE:CHE), Saunders Donald E, sells 500 shares worth $72,160 (NYSE:CHE) empowerednews.net - August 10 at 10:58 AM
	vice president & controller of Chemed Corp (NYSE:CHE), Tucker Arthur V Jr, sells 3,089 shares worth $444,445 (NYSE:CHE) empowerednews.net - August 8 at 9:36 PM
	12:11 pm Chemed increases quarterly cash dividend to $0.26/share from $0.24/share (NYSE:CHE) finance.yahoo.com - August 7 at 8:48 AM
	BRIEF-Chemed Corporation increases quarterly dividend 8.3 pct (NYSE:CHE) www.reuters.com - August 5 at 9:35 PM
	Chemed Corporation Increases Quarterly Dividend 8.3% (NYSE:CHE) finance.yahoo.com - August 5 at 12:37 PM
	CHEMED CORP Financials (NYSE:CHE) finance.yahoo.com - August 4 at 4:21 PM
	Chemed Corp. :CHE-US: Earnings Analysis: Q2, 2016 By the Numbers : August 4, 2016 (NYSE:CHE) www.capitalcube.com - August 4 at 12:22 PM
	Chemed Reports Second-Quarter 2016 Results (NYSE:CHE) www.tmcnet.com - July 27 at 12:46 PM
	BRIEF-Chemed Corp Q2 shr $1.48 (NYSE:CHE) www.reuters.com - July 27 at 12:46 PM
	Chemed Corp. Q2 Profit Advances 2% (NYSE:CHE) www.nasdaq.com - July 27 at 12:46 PM
	Chemed's (CHE) CEO Kevin McNamara on Q2 2016 Results - Earnings Call Transcript (NYSE:CHE) www.msn.com - July 27 at 12:46 PM
	Edited Transcript of CHE earnings conference call or presentation 26-Jul-16 2:00pm GMT (NYSE:CHE) finance.yahoo.com - July 26 at 4:24 PM
	Chemed (CHE) Lags Q2 Earnings, Tops Revenues, View Up (NYSE:CHE) finance.yahoo.com - July 26 at 10:59 AM
	Chemed Corp Earnings Call scheduled for 10:00 am ET today (NYSE:CHE) biz.yahoo.com - July 26 at 10:00 AM
	Chemed posts 2Q profit (NYSE:CHE) sg.finance.yahoo.com - July 25 at 4:29 PM
	Q2 2016 Chemed Corp Earnings Release - After Market Close (NYSE:CHE) biz.yahoo.com - July 25 at 7:07 AM
	Medical Stocks Reporting Early Next Week: GILD, LLY & More (NYSE:CHE) finance.yahoo.com - July 22 at 9:53 AM
	Chemed Corporation : half-yearly earnings release (NYSE:CHE) www.4-traders.com - July 20 at 5:19 PM
	Acadian Asset Management LLC Buys A Little More Chemed Corp (CHE) Stock In The Last Quarter (NYSE:CHE) www.fidaily.com - July 19 at 4:16 PM
	Chemed To Report Second-Quarter 2016 Earnings July 25, Related Conference Call To Be Held On July 26 (NYSE:CHE) www.publicnow.com - July 8 at 12:01 PM
	Chemed Corp. breached its 50 day moving average in a Bearish Manner : CHE-US : June 28, 2016 (NYSE:CHE) www.capitalcube.com - June 28 at 8:23 AM
	Chemed Corp. breached its 50 day moving average in a Bearish Manner : CHE-US : June 13, 2016 (NYSE:CHE) www.capitalcube.com - June 13 at 8:35 AM
	CHEMED CORP Files SEC form 8-K, Change in Directors or Principal Officers (NYSE:CHE) biz.yahoo.com - June 9 at 7:01 AM
	Cherkizovo Group PJSC :CHE-GB: Earnings Analysis: Q1, 2016 By the Numbers : June 9, 2016 (NYSE:CHE) www.capitalcube.com - June 9 at 3:39 AM
	Chemed Corporation Announces the Retirement of Timothy S. O’Toole (NYSE:CHE) www.publicnow.com - June 8 at 5:18 PM
	Chemed Corp. breached its 50 day moving average in a Bullish Manner : CHE-US : June 2, 2016 (NYSE:CHE) www.capitalcube.com - June 2 at 8:14 AM
	Chemed Corporation to Present at the Jefferies 2016 Global Healthcare Conference (NYSE:CHE) www.publicnow.com - May 31 at 2:53 PM
	CHEMED CORP Files SEC form 8-K, Submission of Matters to a Vote of Security Holders (NYSE:CHE) biz.yahoo.com - May 18 at 11:14 AM
	Chemed Corporation Holds Annual Meeting of Shareholders; Board Declares Quarterly Dividend (NYSE:CHE) www.publicnow.com - May 16 at 3:42 PM
	Chemed Corporation to Present at the Bank of America Merrill Lynch 2016 Health Care Conference (NYSE:CHE) www.publicnow.com - May 5 at 3:01 PM
	Chemed Corp. :CHE-US: Earnings Analysis: Q1, 2016 By the Numbers (NYSE:CHE) www.capitalcube.com - May 3 at 10:59 AM
	CHEMED CORP Files SEC form 10-Q, Quarterly Report (NYSE:CHE) biz.yahoo.com - May 2 at 11:17 AM
	Chemed (CHE) Q1 Earnings Miss the Mark, Revenues in Line (NYSE:CHE) finance.yahoo.com - May 2 at 10:53 AM
	Edited Transcript of CHE earnings conference call or presentation 29-Apr-16 2:00pm GMT (NYSE:CHE) finance.yahoo.com - April 29 at 9:01 PM
	Chemed Corp. breached its 50 day moving average in a Bearish Manner : CHE-US : April 29, 2016 (NYSE:CHE) www.capitalcube.com - April 29 at 8:17 AM
	Chemed posts 1Q profit (NYSE:CHE) sg.finance.yahoo.com - April 28 at 6:53 PM
	Chemed Reports First-Quarter 2016 Results (NYSE:CHE) www.publicnow.com - April 28 at 4:36 PM
	Q1 2016 Chemed Corp Earnings Release - After Market Close (NYSE:CHE) biz.yahoo.com - April 28 at 7:07 AM
	Chemed To Report First-Quarter 2016 Earnings April 28, Related Conference Call To Be Held On April 29 (NYSE:CHE) www.publicnow.com - April 15 at 3:27 PM
	CHEMED CORP. (NYSE:CHE): Analysts Maintain an average rating of Buy - Hints News Network (NYSE:CHE) hintsnewsnetwork.com - April 2 at 2:34 PM
	Will Cincinnati firm’s $100M expenditure benefit shareholders? (NYSE:CHE) www.bizjournals.com - March 14 at 5:20 PM